OpenAlex
PricingAboutJobs
Log inGet started
Work

Changes in Symptoms and Adverse Events After Discontinuation of Atomoxetine in Children and Adults With Attention Deficit/Hyperactivity Disorder: A Prospective, Placebo-Controlled Assessment

HTML

Year: 2004
Type: article
Source: Journal of Clinical Psychopharmacology
DOI: 10.1097/01.jcp.0000104907.75206.c2
Authors: Joachim F. Wernicke, Lenard Adler, Thomas Spencer, Scott A. West, Albert J. Allen, John Heiligenstein, Denái Milton, Dustin Ruff, W. Jeffrey Brown, Douglas Kelsey, David Michelson
Institutions: Eli Lilly (United States), New York University, Massachusetts General Hospital, CNS Healthcare
Language: English

Topic: Attention Deficit Hyperactivity Disorder
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: atomoxetine, attention deficit hyperactivity disorder, drug discontinuation, discontinuation syndrome, norepinephrine transporter, adverse events, dose tapering, children and adults
SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company
OpenAlex ID: W2060636676
FWCI: 3.535
Cites: 14
Cited by: 68
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security